Re: Farmas USA
Ya te han salido las news de BIIB
Biogen reported quarterly earnings and revenue that beat analysts' expectations on Wednesday.
The company posted fourth-quarter adjusted earnings per share of $4.50, compared to $4.09 a share in the year-earlier period.
Revenue for the quarter came in at $2.84 billion, against the comparable year-ago figure of $2.64 billion.
Analysts had expected Biogen to report earnings of about $4.08 a share on $2.71 billion in revenue, according to a consensus estimate from Thomson Reuters.
+5% en pre
vamosss a ver si nos mueve hoy al verde el IBB